Академический Документы
Профессиональный Документы
Культура Документы
Elaine Dean
Jacksonville University
Nursing Theory 11
520
Introduction
healthcare choices that lead to action. It is a unique collaboration that enhances the provider-
patient relationship in making healthcare decisions. The process merges together available
healthcare options, healthcare professionals’ knowledge and experiences and patient values and
teaching. The Patient Protection and Affordable Care Act PPACA and other professional
initiatives have recommended the integration of shared decision-making into healthcare practice
(Trugilo-Londrigan, 2016).
Background
The natural process of aging can involve multiple chronic disease processes, frequently
end-stage conditions such as renal disease. The combination of complex comorbid and high
mortality has also led to an increase in the initiation of renal replacement therapy among the
elderly. According to U.S. Renal Data (2012), the median age of the patient with chronic renal
failure was 71 years old. The United States Medicare system current expenditure as reported in
2015 for patients sixty-five and older with chronic renal failure exceeded fifty billion which
represents 20% of all Medicare spending in the age group (U.S. Renal Data, 2015). Choosing
dialysis therapy should be individualized, as the common choice of in-center hemodialysis might
not be a viable or valuable option for some older adults. Establishing a shared decision-making
process during pre-dialysis care can provide balanced information about treatment options that
will close the gap for the underutilization of independent home-based therapies.
RESEARCH PROPOSAL 3
Research Problem
Choosing dialysis therapies have been related to increased stress, anxiety, conflict, and
decisional turmoil. The severity of the disease process with its chronic progression of debilitating
symptoms is a source of mental fatigue for many end-stage renal disease (ESRD) patients.
However, significant differences have been seen in patients who are able to manage the disease
based on knowledge and preparation against those who were poorly prepared and not equipped
with the needed skills. Furthermore, new research shows a direct link between quality of life and
self-care. The choice to make value sensitive decisions based on personal factors and preferences
seems to alleviate symptom responses to the unknown. Shared decision-making has not been
adequately integrated into renal care to deliver the significant outcome it can offer to patients.
Moreover, physician biases, gaps in interdisciplinary care, inability to incorporate the patient
values, beliefs, past experiences, lifestyle, family support system and health status have defied
the ESRD patient of high-quality dialysis care ( Harwood & Clarke, 2014).
Statement of Purpose
The purpose of this study is to examine the role of shared decision-making among the
elderly cohort of end-stage renal disease patients, stages 4 and 5 in choosing independent home-
based therapies versus in-center hemodialysis and its influence on the improved quality of life.
A search was conducted based on published literature between 2011 and 2016. Databases
searched were CINAHL, Cochrane, and PubMed. The search strategy used the following key
terms: shared decision-making, older adults with kidney disease, independent therapies,
significant other, peritoneal dialysis, in-center hemodialysis, and adult end-stage renal disease
patient on dialysis. The review of literature was conducted with a comprehensive focus on
RESEARCH PROPOSAL 4
synthesis of the data. The result of the synthesis allowed the translation of one study into another,
integrating concepts and ideas across the reviewed studies (See Matrix).
The empirical data shows that 25% of the population on dialysis are elderly seventy-five
years and older (U.S. Renal Data, 2012). This growing segment of the dialysis population is
likely to make the decision for renal replacement therapy based on the perceived life expectancy
and quality of life. It is a highly personalized decision that seeks minimal intrusion and
interruption of life patterns. Acceptance of treatment modality and setting in this cohort is
frequently influenced by knowledge, values, beliefs, experiences and lifestyle (Harwood &
Clark, 2014). The literature determined that this value-sensitive decision is usually not
considered due to the lack of a shared decision-making model to engage patient and healthcare
professional in considering the best therapy for the individual patient (Louiselle, O’Connor &
Michuad, 2011).
The following themes emerged from prior studies supporting the need for evidence-
based application of a shared decision-making process towards the uptake of independent home-
based therapies: personal factors (Harwood & Clark, 2014); the engagement of family and or
significant others (Rosenrool, Higuchi, Dutton, Murray, & Stacy, 2013); social support
(Harwood, Wilson, Sontrop, & Alexander, 2012); stressors and coping (Harwood et al., 2012);
decisional conflict and support ( Louiselle et al., 2011).; paternalistic ideology versus ideology of
barriers, facilitators and education (Sondrup & Copland, 2011), Choiu & Chang, 2011),
Harwood & Cark, 2014). A study by Boateng and East (2011) determined that independent
home-based therapy patients rated their quality of life higher than the hemodialysis patient when
RESEARCH PROPOSAL 5
measured using the Kidney Disease Quality of Life (KDQOL) scale. According to Johansson
(2013), a study done in the U.S found that of 1365 dialysis patients 93% were in-center
hemodialysis and only 7% on continuous cycling peritoneal dialysis (CCPD) and of the sample
68-88% had not been presented with the option of dialysis at home. Compared to the U.K 65%
dialysis. The study concluded that in the absence of shared decision-making and knowledge, in-
2013).
Summary of Review
patient to consult with family and friends prior to making a treatment decision. This is
social support. The family desire to be a part of the dialysis modality decision-making process
can be considered as a network of advocacy and support that will decrease the stressors and
improve the coping mechanism of the patient. The acknowledgment of patients’ values,
preference, and beliefs will act as a catalyst towards the ideology of patient participation and
self-care. Additionally, those who deliver education need to account for the diversity of the
patient, understanding about their condition, individual beliefs and barriers to learning. Finally,
education should be anticipated ahead of time before the treatment modality decision is made.
Framework
The diagnosis of end-stage renal disease ESRD and the treatment of maintenance dialysis
means being dependent on a lifelong treatment. The conceptual framework ( See Framework
Diagram ) was organized to establish a relationship between shared decision-making and quality
RESEARCH PROPOSAL 6
of life. The structural concepts establish that shared decision-making promote self-care, which
facilitates health promotion. The patient is empowered to develop skills towards self-
promote therapeutic self-care. The integration of shared decision-making and choice of the
preferred therapy engages the patient, which positively impact lifestyle and quality of life. Once
there is an improved sense of QOL the individual will perform a deliberate action on their own to
maintain health and wellbeing. It is the responsibility of the provider to provide high-quality
information about each dialysis therapy including risk factors modification, choice of medication
with therapies, explanation of therapies and strategies to help incorporate recommended dialysis
treatment plan in everyday living (Hain & Sandy, 2013). Based on an acute awareness and
knowledge of the different dialysis modalities the patient will apply self-management skills such
as taking their own vital signs and weight, being able to insert their needles through the button
hole technique, initiate and terminate their own treatment and maintain the dialysis equipment
with the awareness of infection control practices. The development of autonomy and
independence will move the relationship from dependent and paternalistic, as is common
practice in the in-center setting to an environment of supportive self-care. The renewed sense of
independence will help the patient to gain control of internal and external orientation thereby
Hypotheses
End stage renal disease patients receiving shared decision-making intervention will
choose independent home-based therapy over in-center hemodialysis treatment than those who
End stage renal disease patients receiving shared decision-making intervention will have
improved quality of life with the choice of independent home-based therapy than those who
Research Question
What is the effect of shared decision making in choosing independent dialysis therapy
compared to in-center hemodialysis in promoting quality of life among the older adults with end-
stage renal disease? The independent variable refers to the intervention of shared decision-
practitioners and the patient reach decisions relevant to healthcare choices together. SDM has the
potential to benefit the clinicians, the patient and the health care process in general. It is
associated with improved health outcome, reduction in care and cost variances, decreased
anxiety, increased knowledge and the alignment of care models with the patients’ values. The
2001 Institute of Medical report, Crossing the Quality Chasm highlighted the significance of a
care system that encourages SDM and accommodates patient preference (IOM, 2001). The
Ottawa Decision Support Framework (ODSF) can be used to guide the patient decisional needs.
provides a tailored decisional intervention, and outcome evaluation. The key focus is to facilitate
the development of the patients’ decisional capacity towards personal healthcare decision-
making. This framework is suited for the ESRD patients who lack the clarity regarding treatment
choices, conflicted due to changing circumstances and perceives the choice of therapy will have
RESEARCH PROPOSAL 8
therapy choice rather than the implementation phase (Loiselle, O”Connor & Michaud, 2011).
including everything from physical health, family, education, employment, religious beliefs,
finances, and the environment. QOL is interpreted differently in each group and culture, also
aspects of QOL such as the physical and mental are perceived over time, therefore, the
embodiment of QOL as a public health component can create a common theme to collaborate
with and incorporate community partners, social agency and healthcare partners to maximize
QOL. The Ferrans and Powers Quality of Life Index Dialysis Version 111 (QLI-V111) will be
One of the major constructs in this study is self-efficacy, this refers to the application of
the social, the cognitive, and skill capabilities that an individual uses to form an action. Self-
efficacy is used interchangeably with self-care these are any intentional actions that individuals
uses to take care of themselves physically, mentally and emotionally. A person who is actively
engaged in the process of self-care is known as the self-care agency. The General Self-Efficacy
GSE-10 a self-report measurement scale can be used to measure self-efficacy (Wells &
Anderson, 2011) and Orem’s Self-Care Deficit Nursing theory (SCDNT) can be aptly used to
measure the level of self-care ability (O’Shaughnessy, 2012). The self-care agency is defined as
the individuals’ ability to perform purposeful and deliberate actions to regulate the body’s
environment that promotes life, adaptation, and development. The SF-36 QOL scale and the self-
care agency scale can be used to measure self-care agency (Kalendar & Tosun, 2014). End-stage
RESEARCH PROPOSAL 9
renal disease is defined as the final stage of chronic kidney failure. This means that the kidneys
are functioning below 10% of their functional ability and can no longer support daily life
resulting in the need for dialytic therapies. Independent home-based therapies refer to self-
administration of dialysis therapies in the patient home without direct medical supervision. The
most popular home-based therapy is peritoneal dialysis (PD): a treatment that uses the lining of
the abdomen (peritoneum) and a fluid called dialysate to filter and clean the blood. Two forms of
PD are continuous cycling peritoneal dialysis (CCPD) this uses an automated cycler to perform
multiple exchanges at nights and continuous ambulatory peritoneal dialysis (CAPD), which is
therapies the nursing agency is needed, it is comprised of highly specialized nurses who will
develop specialized education and training founded in theoretical and practical nursing sciences
Design
In the replicated study a descriptive correlation design was used. The design for this
the quality of life outcome of patients who received shared decision-making intervention with
similar patients who did not receive the care intervention. The classic experimental design will
serve as a model for the study design identifying the implementation of the independent variable
(IV) shared-decision making and the measurement of the dependent variable (DV) quality of life
(QOL) (See Appendix). Both study groups will take the pre and posttest and the Ferrans and
Powers Quality of Life Index Dialysis Version 111 (QLI- V111) will be used to measure the
RESEARCH PROPOSAL 10
DV. The experimental group will meet with the multidisciplinary nephrology team monthly in
the outpatient clinic setting for three months with guided support from the Ottowa Decisional
Support Model. The comparison group will have no intervention. Data will be collected at
beginning of the study and at the end of the three-month period. Two categories of weakness
exist in this study design, one is, the assumption that both groups experimental and comparison
are similar. Secondly, there are several threats to the validity of the study these include testing,
mortality, selection and maturation. However, the strength of the design is that the data collected
at the time of pretest allows for evaluation and comparison of prior variables that exist between
The patient population in the replicated study is diagnosed ESRD patients already on
dialysis 18 years and older. A convenience sample was recruited from four major hospitals in
Jordan (two private and two public n = 244). For this study, the population is the elderly cohort
of end-stage renal disease (ESRD) patient stage 4 and 5. The sample will be drawn from a
Veteran Medical Center outpatient nephrology clinic of patients 65 years and older accessing
pre-dialysis care for chronic kidney disease. The recruitment process will include the
presentation of research plans to patients at regular continuity clinic visits and CKD educational
classes. Research flyers will also circulate throughout the hospital for stable ESRD patients that
have longer nephrology appointment span but visit the hospital for other appointments. A cross-
section of participants will be chosen from the 5 full-time nephrologist patient panel.
Demographic information such as gender, ethnicity, age, marital status, and educational level
will be reviewed and compared to the entire sample. Power analysis will be used to determine
the sample size needed in the study for a confidence level of 95% and a level of significance of
RESEARCH PROPOSAL 11
0.05 or less. An additional 5% of participants will be recruited for attrition. The total size of the
sample will then be divided in half, one-half equaling 28 patients will be in the experimental
group and the other half of 28 will be in the comparison group. The renal clinic accumulates at
least 15 new consults each week with a full physician grid of 12-18 patients in the continuity
clinic each day of the week. The percentage of no-show for appointments are about 3%, so, full
recruitment should be accomplished within 2 weeks. Using the electronic record system the
inclusion criteria was refined as determined by following: (a) 65 years and older; (b) diagnosis of
ESRD confirmed by nephrologist; (c) able to communicate verbally; (d) being followed in the
nephrology continuity clinic for 3 months or more; (e) is a veteran receiving care in the
designated Veteran Affairs hospital; (f) stages 4 or 5 end stage renal disease; (g) be willing to
participate in the study. Exclusion criteria will be; (a) inability to communicate; (b) younger than
65; (c) already on other treatment intervention; (d) already a dialysis patient. The strength of the
sample is that there is a high patient count of veterans with ESRD, however, weaknesses include
Setting
The setting will be the C.W Bill Young Medical Center. The strengths of the setting are:
(a) the participants are accessible; (b) electronic medical records are readily available to assist
with research data collection; (c) the monthly CKD educations classes will include shared
decision-making opportunities. The weaknesses are: (a) HIPAA laws and protected health
information; (b) organizational policies and procedures; (c) consent is also needed for chart
reviews
RESEARCH PROPOSAL 12
Ethical Consideration
Jacksonville University and the Institutional Review Board IRB recommendation for the
protection of human subjects will be followed throughout the study. Strict adherence will be
given to the protection of data and participants’ identity using specified numerical coding and
password protected storage of information. All participants will be given handouts on the right to
be protected as human research subjects. All participants will be given full disclosure and
explanation on the study at the beginning and throughout the study. Participants will have a
chance to ask questions and receive answers to their satisfaction. Informed consent will be
participants so they fully understand the process. There will be no data collection on participants
Intervention
The sample will be divided into two equal groups, each group consisting of 23 patients.
The gender ratio will be equal in both groups 3 females and twenty-five males. The materials
developed for this study include consent forms, data collection forms, interview schedules, study
budget, study time -table and educational materials. A registered nurse assistant will be trained to
assist with data collection, recruitment and to cover for absences, illnesses, and unforeseen
events. The study will be divided into four phases: a) the interview phase; b) theory session,
theory and observation session and, the summary session. Telephone contact will be maintained
with all participants over the life of the study to encourage engagement and participation. After
the initial interview, the timeline will be one session each month for three months. The study will
be scheduled for completion within four months. The interview phase will be done individually
with each participant by the author. At this meeting, all relevant information will be
RESEARCH PROPOSAL 13
disseminated. The participants will be advised of all their rights as study subjects and that the
protection of their privacy and data will be reinforced through numeric coding. Time will be
allowed for questions and concerns and participants will be asked to commit to the duration of
the study but also educated on their rights to terminate participation at any time. Demographic
data, pretest and signed consent will be obtained at this meeting (See Appendix). Participants
will be engaged an open discussion on the background of their illness, knowledge of dialysis
therapies and the impact on their quality of life. Additional information if required will be
The theory session will follow a classroom format with extensive education on all the
dialysis therapies and supporting systems. It will incorporate the current practice guidelines as
recommended by the National Kidney Foundation Kidney Disease Outcome Initiative (NKF –
KDOQI, 2015), and current Association for the Advancement of Medical Instrumentation
(AAMI, 2012) standards. It will be three hours long with a presentation from each of the
multidisciplinary team members. The format will comprise largely of visual aids, interactive
computerized sessions, and breakout group sessions. The volunteer department agreed to
The theory and observation session will take place in the dialysis training room where the
participants will visually experience the various dialysis machines. Each machine will be set up
and “dummy” treatment simulated to give the participants a feel of the operational and practical
working of each piece of equipment. They will also be exposed to the advantages and
disadvantages of each treatment options. During this session participants will also have a tour of
the hemodialysis treatment center as agreed ahead of time with the nurse manager, here they can
interact with the actual dialysis patients and see the treatments been performed in real time.
RESEARCH PROPOSAL 14
The summary phase will bring together both groups. Here the post-test and the QLI –
V111 will be completed. After all the relevant data for the study is collected there will be an
informal discussion session with both groups. A Likert questionnaire will be given to all
participants for comparison of dialysis choices at the end of the study. (See Appendix). This data
will be for the dialysis unit focus group to present at the monthly ESRD committee meeting.
As in the study being replicated the Ferrans and Powers Quality of Life Index Dialysis
Version 111 (QLI – V111) will be used as the measurement instrument (See Appendix).The
instrument was developed in 1985 by Carol Ferrans and Marjorie Powers. It is a copyrighted
instrument, however, it is made available for use without charge for non-profit research. There
are two parts to this instrument each part is a 35-item section that measures importance and
satisfaction based on various aspects of life. The items are grouped into four subscales: health
functioning, psychological and spiritual, and social and family. Scores from part 1 are weighted
with scores from part 2. A high score indicates a higher quality of life. The highest potential
response will produce a range of scoring from 0-35. Internal consistency reliability coefficient
(Cronbach’s alpha) for each subscale the quality of life index ranged from 0.89 - 0.92. Cronbach
alpha for the total scale was 0.90. The reported Cronbach alpha was 0.90 and 0.93 with dialysis
patient. The QLI – V111 is a well establish instrument with a background of substantial evidence
of reliability and validity. Good construct and discriminate validity have been reported (Nabolsi,
The trained RN assistant will assist with the recruitment of participants and data
collection. The study will follow the sequential steps for completion as outlined in the research
RESEARCH PROPOSAL 15
timeline (See Appendix D). All participants will complete the demographic data and pretest upon
initiation of the study during their regular clinic appointment. The experimental group will have
a three-hour intervention session on shared decision making for three consecutive months, the
Ottawa Decisional Model will be used as a guide and the sessions will include comprehensive
training and information on each dialysis therapy. The comparison group will have no
intervention. At the end of the research participants will complete the Powers and Ferrans
Quality of Life Index Dialysis Version 111 and the post-test. A Likert-style decisional tool will
The Statistical Package for Social Sciences GradPack 24 with regression will be used to
analyze the data. The objective is to examine the role of shared decision-making among the
elderly cohort of end-stage renal disease patients stages 4 and 5 in choosing independent home-
based therapies versus in-center hemodialysis and its relationship on quality of life. Hypotheses
testing will be conducted to justify rejection of the null hypothesis and accepting the alternative
hypotheses. The level of significance will be assessed for p – value of 0.05 or less which will
conclude statistical significance. The data will be organized and summarized using the
descriptive function of SPSS to obtain output data including frequency, mean, median, and
standard deviation (SD). To establish clarity of the data and to assist with comparison of
relationship example gender/age the results will be reported as percentages. Inferential statistics,
t-test, will be used to determine the strength of the relationship within the sample.
There are several limitations that must be considered when interpreting the results of this
study. The study was designed only to explore the impact of shared decision-making on ESRD
RESEARCH PROPOSAL 16
patient uncertainty, decisional conflict, and decision-making. The needs of dialysis patients are
2). In light of limited time, manpower, and budget this study only track data for a three
month pretest, posttest period. As patient progress through the disease, they might encounter
different problem levels. Future studies should extend the research intervention and observation
time to capture time effects and evaluate decision-making over a longer term.
3). Due to the limitation of the sample the nephrology outpatient clinic in one Veteran
Hospital and the corresponding limited follow-up period of three months the generalizability will
be limited. Further research will be needed to expand time and location to enhance result rigor.
4). There is a gender inequality, this is not intentional but signifies the population that
uses this VA for care. Future studies should extend to a VA that provides women services to
Communication of Findings
The findings of the research study will be first communicated to peers in the dialysis
specialty. A poster presentation will be the next step at the annual nurses week fair. This visual
method will be seen by a larger number of people in a shorter time span. The poster will contain
an immediate view of the hypotheses, description of the sample, method, findings and major
conclusions. Diagrams, graphs, and tables will be included to adequately explain certain areas of
the study. A journal article presentation opportunity might present itself in the future for this
References
Aasen, E. A., Kvangarsnes, M., & Heggan, K. (2011). Perceptions of patient participation
amongst elderly patients with end-stage renal disease in a dialysis unit. Scandinavian
Alligood, M. R. (2014). Nursing theorist and their work (8th ed.). St Louis, MO: Mosby
Elsevier.
Boateng, E. A., & East, L. (2011). The impact of dialysis modality on quality of life: A
Chiou, C. P., & Chung, Y. C. (2011). The effectiveness of multimedia interactive patient
http://dx.doi.org/10.1111/j.1365-2702.2011.03793.x
http://nursingtheories.weebly.com/dorothea-e-orem.html
nursingtheories.weebly.com/dorothea-e-orem.html
Groves, S. K., Burns, N., & Gray, J. R. (2013). Practice of nursing research: Appraisal,
synthesis, and generation of evidence (7th ed.). St Louis, MO: Elsevier Saunders.
Hain, D. J., & Sandy, D. (2013). Empowerment through shared decision making. Nephrology
120. http://dx.doi.org/10.1016/j.ijnurstu.2012.04.003
RESEARCH PROPOSAL 18
Harwood, L., & Clark, A. M. (2014). Dialysis modality decision-making for older adults with
http://dx.doi.org/10.1111/jocn.12582
Harwood, L., Wilson, B., Sontrop, J., & Clark, A. M. (2012). Chronic kidney disease stressors
http://dx.doi.org/10.1111/j.1365-2648.2012.05943.x
Institute of Medicine (2001). Crossing the quality Chasm: A new health system for the 21st
Kalender, N., & Tosun, N. (2014). Determination of the relationship between adequacy of
dialysis and quality of life and self-care agency. Journal of Clinical Nursing, 23, 820-
828.
Loiselle, M. C., O’Connor, A. M., & Michaud, C. (2011). Developing a decision support
Myoungjin, K., & Mallory, C. (2014). Statistics for evidence based practice in nursing.
Nabolsi, M., Wardam, L., & Al-Halabi, J. (2013). Quality of life, depression, adherence to
O’Shaughnessy, M. (2012). Application of Dorothea Orem’s theory of self care to the elderly
models/orem-self-care-deficit
RESEARCH PROPOSAL 19
Rosenroll, A. D., Higuchi, K. S., Dutton, K. S., Murray, M. A., & Stacy, D. (2013). Perspectives
Sondrup, B., & Copeland, M. (2011). Supporting patient choice: An intervention to promote
Stringer, S., & Baharani, J. (2012). Why did I start dialysis? A qualitative study on views and
expectation from an elderly cohort of patients with end-stage renal failure starting
http://dx.doi.org/10.1007/s11255-011-0045-4
U.S. Renal Data System (2012). Atlas of end-stage renal disease in the United States. Retrieved
from usrds.org/atlas.aspx
Wells, J. R., & Anderson, S. T. (2011). Self efficacy and social support in african american
diagnosed with end stage renal disease. ABNF Journal, 22(1), 9-12.
Winterbottom, A., Bekker, H. L., Connor, M., & Mooney, A. (2012). Choosing dialysis
modality: Decision making in a chronic illness context. Health Expectations, 17, 710-
723. http://dx.doi.org/10.111/j.1369-7625.2012.00798.x
RESEARCH PROPOSAL 20
Aasen, E. M., Kvangarsnes, To Theory of Qualitative The in-center Level A culture of change
M., & Heggen, K. (2011). explore discourse exploratory hemodialysis 111 is needed for
Perception of patient the and Theory design environment did not healthcare team to
participation amongst perception of promote patient engage patient in a
elderly patients with end- of patient participa- participation. The social dialogue of shared
stage renal disease in a participa- tion practice of dominance, knowledge and
dialysis unit. Scandinavian tion power and imbalance of intellect and change
Journal of Caring science, amongst knowledge facilitates the social practices to an
26, 61-69. elderly paternalistic ideology. ideology of
doi:10.1111/j.1471- patients Patient struggle for SDM participation.
6712.2011.00904.x with and the focus becomes
ESRD in a therapeutic environment
dialysis versus quality of life
unit.
RESEARCH PROPOSAL 21
Rosenroll, A. D., Higuchi, To Inter- Qualitative The significant other Level Including the
K. S., Dutton, K. S., explore profess- interpretive plays a very important 111 significant other
Murray, M. A., & Stacey, the ional descriptive role in both home based who is usually the
D. (2013). Perspective of experience Shared study and in-center therapy caregiver in the
significant others in of the Decision options. Significant deliberate choice of
dialysis modality decision- dialysis Model others need to be treatment modality
making: A qualitative modality included in the shared can improve patient
study. The CANNT decision- decision making process and significant other
Journal, 23(4). making to meet the need of the outcome.
process as family unit. Support
perceived should also be offered to
by the meet the emotional and
significant physical need of the care-
other. giver.
Harwood, L., Wilson, B., To N/A Perspective The CKD patients Level 1V The plan of care
Sontrop, J., & Clark, A. M. evaluate Correla- experience a lot of stress need to involve
(2012). Chronic kidney whether tional including psychosocial, intervention to help
disease stressors influence CKD physiological and patients to deal with
choice of dialysis modality. stress logistical. There is a stressors to promote
Journal of Advanced levels and direct link between stress positive health
nursing, 68(11), 2454- coping and choice of modality behaviors and
2465. doi:10.11111/j.1365- strategies selection. This ultimately increase
2648.2012.05943 influence population of patients choice in home
the will need decisional based dialysis
decision support intervention therapy. The stress
to initiate included in the shared inventory scale can
treatment decision making process a be a valid tool.
with HD to prevent decisional
vs. PD conflict from occurring.
RESEARCH PROPOSAL 22
Testing the N/A Quasi- The experimental group Level The educational
Choiu, C. P., & Chung, Y. efficacy of Experi- demonstrated increased 111 process should be
C. (2011). Effectiveness of interactive mental knowledge, less started early. As
multimedia interactive multimedia design. uncertainty and reduced soon as kidney
patient education on DVD as an Quanti- decision regret with the injury is determined
knowledge, uncertainty and educational tative interventional interactive and continued
decision-making in patients tool for multimedia DVD through
with end-stage renal patients educational tool. In the maintenance
disease. Journal of Clinical with ESRD control group it was dialysis therapy.
Nursing, 21,1233-1231. to enhance determined that simple Close monitoring of
doi:10.1111/j.1365- knowledge educational leaflet was kidney disease
2702.2011.03793.x and an inadequate tool to usually starts with
decision- provide full scope eGFR <60 more so
making and education on the in comorbids such
decrease complicated therapy as HTN and
uncertainty. options. diabetes.
RESEARCH PROPOSAL 24
ESRD
Diagram 1. Framework
Shared Decision
Therapeutic Self-Care
Diet – Renal diet, fluid Health Requisites
restriction. Compliance with treatment regimen
Elimination – decrease in Knowledge of potential
urinary output, adequate bowel complication with treatment
movement regimen example infection.
Health
Nursing Safety - access care Acceptance of changes in self Promotion
Medication –identification of
Agency renal medication
image to facilitate progression of
chronic disease process example
Recreation – modification of skin and body changes.
exercise. Accommodate and incorporate
dialysis therapy into lifestyle.
Tolerates treatment plan.
1. Age
______
2. Years of Education
______
3. Marital Status
a. Married
b. Single
4. Gender
a. Male
b. Female
5. Ethnicity
a. African-American
b. White
c. Other ______
Appendix
Test Name: Shared decision-making Name:
26
Appendix
Ferrans and Powers
QUALITY OF LIFE INDEX©
DIALYSIS VERSION - III
PART 1. For each of the following, please choose the answer that best describes how satisfied you are with that
area of your life. Please mark your answer by circling the number. There are no right or wrong answers.
Moderately Dissatisfied
Slightly Dissatisfied
Moderately Satisfied
Very Dissatisfied
Slightly Satisfied
Very Satisfied
HOW SATISFIED ARE YOU WITH:
1. Your health? 1 2 3 4 5 6
Page 1
Appendix
Moderately Dissatisfied
Moderately Satisfied
Slightly Dissatisfied
Very Dissatisfied
Slightly Satisfied
Very Satisfied
HOW SATISFIED ARE YOU WITH:
25. How well you can take care of your financial needs? 1 2 3 4 5 6
26. The things you do for fun? 1 2 3 4 5 6
Page 2
Appendix
PART 2. For each of the following, please choose the answer that best describes how important that area of your
life is to you. Please mark your answer by circling the number. There are no right or wrong answers.
Moderately Unimportant
Moderately Important
Slightly Unimportant
Very Unimportant
Slightly Important
Very Important
HOW IMPORTANT TO YOU IS:
1. Your health? 1 2 3 4 5 6
2. Your health care? 1 2 3 4 5 6
Page 3
Appendix
Moderately Unimportant
Moderately Important
Slightly Unimportant
Very Unimportant
Slightly Important
Very Important
HOW IMPORTANT TO YOU IS:
17. Taking care of family responsibilities? 1 2 3 4 5 6
18. Being useful to others? 1 2 3 4 5 6
© Copyright 1984 & 1998 Carol Estwing Ferrans and Marjorie J. Powers (Do not use without
permission).
Page 4
Appendix
Data Collection Spreadsheet
Educational Marital Decisional Tool
Nunerical ID Age Gender Pretest QLI Scores Post Test
Level Status Outcome
Page 5
Appendix
Research Timeline
Page 6
Appendix
Data Analysis Shells
Page 7
Appendix
Likert Scale Decision tool
What matters Strongly Disagree Strongly Not
to me for this disagree agree applicable
decision
1. Having
someone else in
charge of doing
my dialysis
2. Seeing my
health care
team more often
3. Having ability
to go to work or
school
4. Having
flexible daily
dialysis
5. Providing care
for myself at
home
6. Having set
schedule at
dialysis center
7. Having the
ability to travel
8. Avoiding
needles
Page 8
Appendix
JACKSONVILLE UNIVERSITY
SUBJECT’S NAME:
TITLE OF INVESTIGATION: Shared decision making and its effects on the upyake of
independent home-based therapies versus in-center hemodialysis and its influence on quality of
life
The purpose of this study is to see if more individuals will choose dialysis at home if allowed to
make that choice with the doctor. You qualify to participate in this study because you have
kidney disease and will possibly need dialysis in the future. If you choose to participate in this
study you will be provided with information and decisional making training. You have a right
not to participate in this study and if you exercise that right you will not be treated differently for
doing so.
The benefits of study are to help us understand if making a decision with the doctor would help
more patients choose dialysis in the comfort of their homes than going to a clinic three days per
week, and would it improve their quality of life. You may not benefit directly from this study
over and above the benefits normally associated with your continuity of care in the nephrology
clinic.
I do not anticipate any risk to you participatig in this study. If at any point you do not wish to
continue, you have the right to withdraw from the study, without penalty, at any time.
ALTERNATIVES:
There are no alternatives to participating in this study. Your clinic appointments and treatment
prescribed by the nephrologist will remain the same.
COSTS / COMPENSATION:
There are no cost to you participating in this study. You will obtain valuable information and
training for your time.
Page 9
Appendix
CONFIDENTIALITY:
Your privacy and your participation in this study will be protected under HIPAA Laws. All
information will be kept confidential and anonymous. By anonymous, that your name will not
appear anywhere and no one except me will know about your specific answers. By confidential, I
will assign a number to your response, and only I will have the key to indicate which number
belong to which participant. In any article I write or any presentation that I make, I will use a
made-up name for you, and I will not reveal details or I will change details about where you
work, where you live, and ant other personal information about you.
CONFLICT OF INTEREST:
Your participation in this study is completely voluntary. You may refuse to participate or
withdraw at any time. If you choose to withdraw from this study your care will not be affected.
CONSENT TO PARTICIPATE:
You may contact Elaine Dean at Elaine.Dean@va.gov if you have any questions or concerns
regarding this study. If you have questions about your rights as a research volunteer, you may
contact Dr. Mike Nancarrow, IRB Chair, mnancar@ju.edu or Dr. Adele Hanlon, IRB Assistant
Chair, ahanlon@ju.edu at Jacksonville University, 2800 University Boulevard North,
Jacksonville, FL 32211.
______________________________________ ____________________
Subject or Parent if Subject is a Minor Date
______________________________________ ___________________
Investigator Obtaining Consent Date
Page
10
Appendix
Nursing Theory and Research 11
Item Amount
Personnel
1.
2.
3.
4.
5.
Category Total: $0.00
Personnel Justification:
Equipment
1.
2.
3.
4.
Category Total: $0.00
Equipment Justification:
Supplies/Expenses
1.
2.
3.
4.
5.
6.
7.
Category Total: $0.00
Supplies/Expenses Justification:
Page
11
Appendix
Travel
1.
2.
3.
Category Total: $0.00
Travel Justification:
TOTAL $0.00
Page
12
Appendix
Approach to analysis – Examine the difference between pretest and posttest scores
Comparison of experimental and comparison group
Identify differences between the two sample groups.
Page
13